产品封面图
文献支持

HPAF-II细胞

收藏
  • ¥1800
  • EK-Bioscience已认证
  • CCC-Y1746
  • 2025年07月15日
    avatar
    品牌商
    12钻石会员
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    HPAF-II/HPAF-II细胞系/HPAF-II细胞株/HPAF-II人胰腺癌细胞

    Cell line name HPAF-II

    Synonyms HPAF II; HPAFII; HPAF-2; HPAF2; HPAF/CD18; CD18/HPAF; HPAF-II/CD18; CD-18; CD18; CD 18

    Accession CVCL_0313

    Resource Identification Initiative To cite this cell line use: HPAF-II (RRID:CVCL_0313)

    Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: COSMIC cell lines project.

    Part of: KuDOS 95 cell line panel.

    Part of: MD Anderson Cell Lines Project.

    Part of: NCI RAS program mutant KRAS cell line panel.

    Population: Caucasian.

    Doubling time: 26 hours (PubMed=2734279); 70 hours (PubMed=25984343).

    Microsatellite instability: Stable (MSS) (Sanger).

    Omics: Array-based CGH.

    Omics: CRISPR phenotypic screen.

    Omics: Deep exome analysis.

    Omics: Deep proteome analysis.

    Omics: DNA methylation analysis.

    Omics: Metabolome analysis.

    Omics: Protein expression by reverse-phase protein arrays.

    Omics: Proteome analysis by 2D-DE/MS.

    Omics: shRNA library screening.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Caution: Could not find proof that the CD18 subline of HPAF is really HPAF-II but many indirect evidences points in this direction. If someone read this comment and can help us, please do.

    Caution: TP53 mutation indicated incorrectly as being at c.452C>T in PubMed=1764370.

    Misspelling: HPAF11; PubMed=25984343.

    Misspelling: Hapaf-II; Note=Occasionally.

    Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.

    PubMed=1764370; DOI=10.1038/bjc.1991.467; PMCID=PMC1977874

    Barton C.M., Staddon S.L., Hughes C.M., Hall P.A., O'Sullivan C., Kloppel G., Theis B., Russell R.C.G., Neoptolemos J., Williamson R.C.N., Lane D.P., Lemoine N.R.

    Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.

    Br. J. Cancer 64:1076-1082(1991)

     

    PubMed=11787853; DOI=10.1007/s004280100474

    Moore P.S., Sipos B., Orlandini S., Sorio C., Real F.X., Lemoine N.R., Gress T.M., Bassi C., Kloppel G., Kalthoff H., Ungefroren H., Lohr J.-M., Scarpa A.

    Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.

    Virchows Arch. 439:798-802(2001)

     

    PubMed=12068308; DOI=10.1038/nature00766

    Davies H.R., Bignell G.R., Cox C., Stephens P.J., Edkins S., Clegg S., Teague J.W., Woffendin H., Garnett M.J., Bottomley W., Davis N., Dicks E., Ewing R., Floyd Y., Gray K., Hall S., Hawes R., Hughes J., Kosmidou V., Menzies A., Mould C., Parker A., Stevens C., Watt S., Hooper S., Wilson R., Jayatilake H., Gusterson B.A., Cooper C.S., Shipley J.M., Hargrave D., Pritchard-Jones K., Maitland N.J., Chenevix-Trench G., Riggins G.J., Bigner D.D., Palmieri G., Cossu A., Flanagan A.M., Nicholson A., Ho J.W.C., Leung S.Y., Yuen S.T., Weber B.L., Seigler H.F., Darrow T.L., Paterson H.F., Marais R., Marshall C.J., Wooster R., Stratton M.R., Futreal P.A.

    Mutations of the BRAF gene in human cancer.

    Nature 417:949-954(2002)

     

    PubMed=12692724; DOI=10.1007/s00428-003-0784-4

    Sipos B., Moser S., Kalthoff H., Torok V., Lohr J.-M., Kloppel G.

    A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform.

    Virchows Arch. 442:444-452(2003)

     

    PubMed=15126341; DOI=10.1158/0008-5472.CAN-03-3159

    Heidenblad M., Schoenmakers E.F.P.M., Jonson T., Gorunova L., Veltman J.A., van Kessel A.G., Hoglund M.

    Genome-wide array-based comparative genomic hybridization reveals multiple amplification targets and novel homozygous deletions in pancreatic carcinoma cell lines.

    Cancer Res. 64:3052-3059(2004)

     

    PubMed=15367885; DOI=10.1097/00006676-200410000-00004

    Loukopoulos P., Kanetaka K., Takamura M., Shibata T., Sakamoto M., Hirohashi S.

    Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity.

    Pancreas 29:193-203(2004)

     

    PubMed=15367897; DOI=10.1097/00006676-200410000-00016

    Rajasekaran S.A., Gopal J., Espineda C., Ryazantsev S., Schneeberger E.E., Rajasekaran A.K.

    HPAF-II, a cell culture model to study pancreatic epithelial cell structure and function.

    Pancreas 29:e77-e83(2004)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由上海酶研生物科技有限公司提供;

    *发表【英文论文】请标注:From Shanghai EK-Bioscience Biotechnology Co., Ltd.

    相关实验
    • V294.PART II,Chapter 5 细胞粘附实验(英文版)

      PART II:BASIC CELL MIGRATION AND RELATED ASSAYS vol.294 Guan J.-L. (ed.) Cell Migration-Developmental Methods and Protocols Chapter 5 Cell-Adhesion Assays Dennis F. Kucik and Chuanyue Wu Summary One of the most important

    • 应用MHC II型四聚体观察抗原特异性CD4+ T细胞

      0:00 应用MHC II型四聚体观察抗原特异性CD4+ T细胞0 0:09 内容简介9 0:21 订阅内容21 1:05 T细胞染色65 3:21 试剂和仪器201 5:44 在工作区组装原料和仪器344 6:04 第一步: 分离PBMC 364 8:51 第二步: 分离CD4+细胞531 11:01 第三步: 体外扩大培养661 13:34 第四步: 利用四聚体的染色观察T细胞814 15:33 结论933   本视频来源于网络,如有异议请联系

    • V294.PART II,Chapter 4 细胞迁移实验之Dunn趋化迁移培养皿法及时序显微镜分析法

      PART II:BASIC CELL MIGRATION AND RELATED ASSAYS vol.294 Guan J.-L. (ed.) Cell Migration-Developmental Methods and Protocols Chapter 3 Analysis of Cell Migration Using the Dunn Chemotaxis Chamber and Time-Lapse Microscopy Claire M. Wells

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥680
    上海联迈生物工程有限公司
    2025年09月10日询价
    ¥600
    上海再康生物科技有限公司
    2025年11月21日询价
    ¥600
    上海信裕生物科技有限公司
    2025年07月12日询价
    ¥500
    北京百奥创新科技有限公司
    2025年07月09日询价
    ¥1800
    上海酶研生物科技有限公司
    2026年01月04日询价
    文献支持
    HPAF-II细胞
    ¥1800